SYS-CON MEDIA Authors: Michael Bushong, Eric Brown, Gilad Parann-Nissany, Kevin Benedict, PR.com Newswire

News Feed Item

Dr. Adam J. Scheiner Holds Complimentary Sculptra Event on Anti-Aging Facial Injection Treatment

Learn How You Can Stop the Clock and Create a Foundation for a More Youthful You

TAMPA, FL -- (Marketwired) -- 03/21/14 -- Adam J. Scheiner, M.D., an expert in laser eyelid and facial plastic surgery, is inviting the public to a complimentary seminar on Sculptra Aesthetics; an anti-aging facial injection treatment, on Thursday, March 27th from 6 to 8PM.

During the event, Dr. Scheiner will provide mini-consultations and Moria Daub from Sculptra Aesthetic, will provide a presentation about the treatment's proven effects. Wine and hors d'oeuvres will be served. Special savings on Sculptra treatments will be available only to attendees.

To attend the event, please contact Toni Bagnasco at 813 367-1915 x 2245.

"People are often concerned about wrinkles and bags as they age, but so often loss of facial volume is overlooked. Yet, volume loss is a key contributor to making people look older and gaunter. Come to our seminar and learn more on why Sculptra is a great volume restoration treatment that's non-invasive that can last up to two years," says Dr. Adam J. Scheiner.

For more information on Sculptra, visit http://www.adamscheinermd.com/sculptra.

About Dr. Adam J. Scheiner

Based in Tampa, Dr. Adam Scheiner is a world-renowned eyelid and facial cosmetic surgeon, specializing in treatment of festoons. His approach to facial rejuvenation, called Perfect Proportions, is broadly recognized for helping patients in achieving powerful yet natural results. He treated two complex causes of Festoons for the Dr. Oz and The Doctors TV shows. He is also the author of "The True Definition of Beauty" which can be found on Amazon.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Toni Bagnasco
813 367-1915 x 2245

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.